Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2

• Mark Thursz^1​, Fouzia Sadiq^1​,†​, Julia A. Tree^2​, Peter Karayiannis^3​,4​, David W. C. Beasley^{5​,6​,7​}, Wanwissa Dejnirattisai^8​, Juthathip Mongkolsapaya^8​, Gavin Screaton^9​, Matthew Wand^2​, Michael J. Elmore^2​, Miles W. Carroll^2​, Ian Matthews^4​ and Howard Thomas^1​,4​
• View Affiliations Hide Affiliations

  ^1​ Department of Metabolism, Digestion and Reproduction, Imperial College, London W2 1NY, UK ^2​ UK Health Security Agency, Porton Down, Salisbury, SP4 0JG, UK ^3​ University of Nicosia Medical School, Nicosia, Cyprus ^4​ RioTech Pharmaceuticals, 49 Arrivato Plaza, St Helens, WA10 1GH, UK ^5​ Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1019, USA ^6​ Centre for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555-1019, USA ^7​ Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555-1019, USA ^8​ Nuffield Department of Medicine, Old Road Campus, Oxford OX3 7BN, UK ^9​ Medical Science Division, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK ^†​ Present address: Directorate of Research, Shifa Tameer-e-Millat University, Islamabad, Pakistan

  *Correspondence: Peter Karayiannis, [email protected] *Correspondence: Howard Thomas, [email protected]
• Published: 26 July 2023 https://doi.org/10.1099/jgv.0.001876